From the Washington Post, U.S. News & World Report, Wall Street Journal:

Children taking stimulant drugs such as Ritalin to treat attention-deficit hyperactivity disorder are several times as likely to suffer sudden, unexplained death as children who are not taking such drugs, according to a study published yesterday that was funded by the Food and Drug Administration and the National Institute of Mental Health.

… In a press briefing called on short notice yesterday, FDA officials said that given the seriousness of ADHD and the rarity of sudden death — which strikes fewer than 1 in 10,000 children — the benefits of the drugs outweigh their risks. Agency officials urged parents to discuss concerns with doctors rather than deciding on their own to discontinue a child’s medication.

This entry was posted on Tuesday, June 16th, 2009 at 12:20 pm and is filed under ADHD, drugs, research news. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.